Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

4th Tecan Symposium Enjoys Chinese Success

Published: Thursday, November 24, 2011
Last Updated: Wednesday, November 23, 2011
Bookmark and Share
Experts from around the globe discusses translational medicine in symposium.

Tecan recently hosted the fourth annual Tecan Symposium, welcoming leading genomics, proteomics and biobanking experts from around the globe to discuss this year’s topic; Translational Medicine: From bench to bedside and back.

Held outside of Europe for the first time, the 2011 Tecan Symposium was in Shanghai, China, reflecting Tecan’s strong commitment to the Asian market and the growing importance of China as a major center for genomics and clinical research.

The two-day event was divided into four topics - current trends in translational research, clinical aspects of translational medicine, the growing importance of biobanking and the impact of technology on translational science - and explored a wide range of current hot topics in this fast-growing area of life science research.

The high quality program for this year’s event was opened by Professor Huanming Yang, President of China’s very own ‘genome factory’, the Beijing Genomics Institute (BGI).

A succession of enlightening presentations then charted the contributions that genomics and, more recently, proteomics have played in enhancing our understanding of the world around us, and how these breakthroughs are being applied to global health issues.

The second day’s program concentrated on the technologies behind the science, looking at why “biobanks are more than just a place to store freezers,” the huge tasks that face the exciting global initiatives now being undertaken and what we can learn from the mummified remains of our ancient past.

Fittingly, the Symposium’s final presentation was by Dr Colin Campbell from the University of Edinburgh, who discussed an exciting collaborative project first conceived during a chance meeting at the very first Tecan Symposium in Zurich.

Alongside the scientific content, Tecan’s local representatives - Tecan (Shanghai) Trading Company Ltd - arranged a number of social events for delegates, including a river cruise to provide a more relaxed environment to discuss the day’s topics, and a visit to a traditional Chinese tea house to celebrate the rich cultural heritage of Shanghai itself.

Overall, the 4th Tecan Symposium was hailed a great success, once again highlighting the innovation-driven, customer-focused approach that has made Tecan a leading provider within the life sciences sector.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Zebrafish Reveal Drugs that may Improve Bone Marrow Transplant
Compounds boost stem cell engraftment; could allow more matches for patients with cancer and blood diseases.
New Material Forges the Way for 'Stem Cell Factories'
Researchers have discovered the first fully synthetic substrate with potential to grow billions of stem cells. The researchcould forge the way for the creation of 'stem cell factories' - the mass production of human embryonic (pluripotent) stem cells.
Liver Regrown from Stem Cells
Scientists have repaired a damaged liver in a mouse by transplanting stem cells grown in the laboratory.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
'Google Maps' for the Body
Scientists have revealed research that uses previously top-secret technology to zoom through the human body down to the level of a single cell that could be a game-changer for medicine.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!